Not logged in
Share
Save
Share
Save
Share
Save
Share
SaveThe microenvironment cell index is a novel indicator for the prognosis and therapeutic regimen selection of cancers
Yang, Xian-Yan; Chen, Nian; Wen, Qian; Zhou, Yu; Zhang, Tao; Zhou, Ji; Liang, Cheng-Hui; Han, Li-Ping; Wang, Xiao-Ya; Kang, Qing-Mei; Zheng, Xiao-Xia; Zhai, Xue-Jia; Jiang, Hong-Ying; Shen, Tian-Hua; Xiao, Jin-Wei; Zou, Yu-Xin; Deng, Yun; Lin, Shuang; Duan, Jiang-Jie; Wang, Jun; Yu, Shi-Cang
Share
SaveA phase II safety and efficacy study of PM8002/BNT327 in combination with chemotherapy in patients with EGFR-mutated non-small cell lung cancer (NSCLC)
Wu, Y-L.; Wang, Z.; Cheng, Y.; Fang, J.; Meng, X.; Pan, Y.; Zhao, H.; Zhao, Y.; Su, H.; Sun, M.; Zhou, T.; Duan, P.; Lv, D.; Wang, Y.; Du, Y.; Zuo, W.; Zhang, P.; Zhang, T.
Share
SavePhase I study of SHR-A2102, a nectin-4 targeted ADC, in patients with advanced solid tumors
Zhong, H.; Zhong, R.; Qiao, R.; Lan, Q.; Yan, M.; Zhang, T.; Chen, K.; Huang, J.; Hong, H-M.; Lin, G.; Li, X.; Huang, Y.; Song, L.
Share
SaveEAGER: A randomized, controlled, multicenter trial of electro-acupuncture in gastric cancer patients undergoing adjuvant chemotherapy
Zhang, H-B.; Zhu, Y.; Mao, J. J.; Chang, X-S.; Peng, J-J.; Wu, X-Y.; Wang, W.; Diao, D-C.; Li, Y.; Zhang, H-Y.; Zhai, X-H.; Yu, J-L.; Wang, W.; Zhou, J-X.; Huang, Z-L.; Zhang, T.; Liu, Y-H.; Zhou, R.; Ma, H-C.; Chen, Y-D.
Share
SaveA randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease
Guo, Zhiyong; Zhao, Qiang; Jia, Zehua; Huang, Changjun; Wang, Dongping; Ju, Weiqiang; Zhang, Jian; Yang, Lu; Huang, Shanzhou; Chen, Maogen; Zhu, Xiaofeng; Hu, Anbin; Ma, Yi; Wu, Linwei; Chen, Yinghua; Han, Ming; Tang, Yunhua; Wang, Guodong; Wang, Linhe; Li, Lifen; Xiong, Wei; Zhang, Zhiheng; Shen, Yuekun; Tang, Zhaoxia; Zhu, Caihui; Chen, Xiaoxiang; Hu, Xiaoguang; Guo, Yiwen; Chen, Honghui; Ma, Yihao; Zhang, Tao; Huang, Shunwei; Zeng, Ping; Lai, Simei; Wang, Tielong; Chen, Zhitao; Gong, Jinlong; Yu, Jia; Sun, Canhui; Li, Chang; Tan, Haiyi; Liu, Yao; Dong, Yuqi; Sun, Chengjun; Liao, Bing; Ren, Jun; Zhou, Zhenhai; Andrea, Schlegel; Bjorn, Nashan; Cai, Changjie; Gong, Fengqiu; Rong, Jian; Huang, Wenqi; Guan, Xiangdong; Clavien, Pierre-Alain; Stefan, Tullius G.; Huang, Jiefu; He, Xiaoshun
Share
SaveMultiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non-small-cell lung cancer characterizes the features of response to PD-1 blockade plus chemotherapy
Wu, Fengying; Jiang, Tao; Chen, Gongyan; Huang, Yunchao; Zhou, Jianying; Lin, Lizhu; Feng, Jifeng; Wang, Zhehai; Shu, Yongqian; Shi, Jianhua; Hu, Yi; Wang, Qiming; Cheng, Ying; Chen, Jianhua; Lin, Xiaoyan; Wang, Yongsheng; Huang, Jianan; Cui, Jiuwei; Cao, Lejie; Liu, Yunpeng; Zhang, Yiping; Pan, Yueyin; Zhao, Jun; Wang, LiPing; Chang, Jianhua; Chen, Qun; Ren, Xiubao; Zhang, Wei; Fan, Yun; He, Zhiyong; Fang, Jian; Gu, Kangsheng; Dong, Xiaorong; Zhang, Tao; Shi, Wei; Zou, Jianjun; Bai, Xuejuan; Ren, Shengxiang; Zhou, Caicun
Share
SaveA multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy
Peng, Guangxin; He, Guangsheng; Chang, Hong; Gao, Sujun; Liu, Xinjian; Chen, Tong; Li, Pei; Han, Bing; Miao, Miao; Ge, Zheng; Ge, Xiaoyan; Li, Fei; Li, Yingmei; Wang, Shunqing; Wang, Yi; Shen, Yaqi; Zhang, Tao; Zou, Jianjun; Zhang, Fengkui
Share
SavePyrotinib in combination with trastuzumab and docetaxel as neoadjuvant treatment for HER2-positive early or locally advanced breast cancer (PHEDRA): A randomized, double-blind, multicenter, phase 3 study
Wu, Jiong; Liu, Zhenzhen; Yang, Hongjian; Tang, Jinhai; Wang, Kun; Liu, Yunjiang; Wang, Haibo; Fu, Peifen; Zhang, Shuqun; Liu, Qiang; Jiang, Zefei; Wang, Shusen; Huang, Jian; Wang, Chuan; Wang, Shu; Wang, Yongsheng; Zhen, Linlin; Zhu, Xiaoyu; Wu, Fei; Zhang, Tao; Zou, Jianjun
Share
SaveClinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)
Xu, Jianming; Li, Yi; Fan, Qingxia; Shu, Yongqian; Yang, Lei; Cui, Tongjian; Gu, Kangsheng; Tao, Min; Wang, Xiuwen; Cui, Chengxu; Xu, Nong; Xiao, Juxiang; Gao, Quanli; Liu, Yunpeng; Zhang, Tao; Bai, Yuxian; Li, Wei; Zhang, Yiping; Dai, Guanghai; Ma, Dong; Zhang, Jingdong; Bai, Chunmei; Huang, Yunchao; Liao, Wangjun; Wu, Lin; Chen, Xi; Yang, Yan; Wang, Junye; Ji, Shoujian; Zhou, Hui; Wang, Yan; Ma, Zhuo; Wang, Yanqi; Peng, Bo; Sun, Jiya; Mancao, Christoph
Share
SaveHenagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial
Weng, Jianping; Zeng, Longyi; Zhang, Yuwei; Qu, Shen; Wang, Xueying; Li, Ping; Fu, Liujun; Ma, Boqing; Ye, Shandong; Sun, Jiao; Lu, Weiping; Liu, Zhiwen; Chen, Daoxiong; Cheng, Zhifeng; Liu, Haiyan; Zhang, Tao; Zou, Jianjun
Share
SaveCamrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
Zhou, Caicun; Chen, Gongyan; Huang, Yunchao; Zhou, Jianying; Lin, LiZhu; Feng, Jifeng; Wang, Zhehai; Shu, Yongqian; Shi, Jianhua; Hu, Yi; Wang, QiMing; Cheng, Ying; Wu, Fengying; Chen, Jianhua; Lin, Xiaoyan; Wang, Yongsheng; Huang, Jianan; Cui, Jiuwei; Cao, Lejie; Liu, Yunpeng; Zhang, Yiping; Pan, Yueyin; Zhao, Jun; Wang, LiPing; Chang, Jianhua; Chen, Qun; Ren, Xiubao; Zhang, Wei; Fan, Yun; He, Zhiyong; Fang, Jian; Gu, Kangsheng; Dong, XiaoRong; Zhang, Tao; Shi, Wei; Zou, Jianjun
Share
SaveHenagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial
Lu, Juming; Fu, Liujun; Li, Yan; Geng, Jianlin; Qin, Li; Li, Ping; Zheng, Hailong; Sun, Zilin; Li, Yanbing; Zhang, Lihui; Sun, Yadong; Chen, Daoxiong; Qin, Guijun; Lu, Weiping; Guo, Yushan; Zhang, Yuwei; Liu, Haiyan; Zhang, Tao; Zou, Jianjun
Share
Save
Share
Save
Share
Save
Share
Save